Changchun hi tech fell more than 8% in intraday diving

Big Pharma CCHT’s Domination Unlikely to Fade Soon Despite Official Bulk Buying

The producer of long-acting growth hormone acupunctures, vaccines and other drugs, looks set to offset the effects of so-called “centralized procurement” on its product prices with more aggressive expansion into private hospitals. So far, its monopoly appears unshakable, but with more competitors upping the stakes, how long will it last?

Exclusive Interview with Ray Hu, Founder and Managing Partner of Blue Lake Capital

Although the past two years have witnessed great changes in the world, the digitization trend remains unchanged. Of all the uncertainties facing us, digitization is still the surest opportunity nowadays.

Successful Multinational Corporations in China Series: Qualcomm China [2/2]

Since China's reform and opening-up, many multinational corporations and groups have achieved success in China. They have not only been successful in their fields, but some also benefitted from wise M&A moves or investments. To answer these questions EqualOcean launches its Successful Multinational Corporations in China and analyzes the critical points of investing in China for investors and people interested in such a topic.

Chinese Digital Twin Visualization Company UINO Technology Completed Series C Funding

UINO Technology constantly refreshes its platform capabilities and builds the leading digital twin development ecology in China.

A Closer Look at China’s Cloud Service Market, Guessing Who Will Succeed? [2/2]

China’s cloud service market is in the spotlight. Each company in this market has its specialization of business. In this paragraph, we will discuss the current situation and future predictions of Alibaba Cloud, Huawei Cloud, Tencent Cloud, and JD.com’s Cloud.